Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Review
Early and late outcomes of bevacizumab plus chemotherapy versus chemotherapy alone as a neoadjuvant treatment in HER2-negative nonmetastatic breast cancer: a meta-analysis of randomized controlled trials
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,870 | Dovepress* | 7,508+ | 876 | 8,384 | |
| PubMed Central* | 362 | 189 | 551 | ||
| Totals | 7,870 | 1,065 | 8,935 | ||
| *Since 12 December 2018 | |||||
View citations on PubMed Central and Google Scholar